{
      "ptx_code": "PTX121",
      "chem_name": "Testosterone",
      "casrn": "58-22-0",
      "dtxsid": "DTXSID8022371",
      "smiles": "[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
      "inchikey": "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
      "label": "PTX121 | Testosterone",
      "drugbank_id": "DB00624",
      "use_class": "Endogenous",
      "tox_class": "Hepatotoxicity",
      "chem_name_user": "Testosterone",
      "mw_g_mol": "288.431",
      "solubility_h2o_mol_liter": "9.12237e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "7.04681e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "5.54031710986631",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "15.99",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "3.32",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "3.54999999901819",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "0.138233120243267",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "baseline_drerio": "50.75747401649",
      "baseline_dmagna": "41.8469073193521",
      "baseline_celegans": "92.3097395358733",
      "baseline_xlaevis": "52.4789335078144",
      "baseline_dmelanogaster": "358.364516008278",
      "baseline_cells": "5.30104191018608e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "7.3277956378535e-06",
      "moa_drugbank": "The androgen receptor exists in the cytoplasm bound to the heat shock proteins HSP90, HSP70, and other chaperones.[A187114] After binding to an androgen, the androgen receptor dissociates from HSP90 and undergoes a conformational change to slow the rate of dissociation from the androgen receptor.[A187114] The androgen-receptor complex is transported into the nucleus where it binds to DNA and recruits other transcriptional regulators to form a pre-initiation complex and eventually induce expression of specific genes.[A187114]\n\nTestosterone and its active metabolite dihydrotestosterone (DHT) antagonize the androgen receptor to develop masculine sex organs including the prostate, seminal vesicles, penis, and scrotum.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]\n\nAntagonism of the androgen receptor is also responsible for the development of secondary sexual characteristics including facial and body hair, enlargement of the larynx, thickening of the vocal cords, and changes in muscle and fat distribution.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]",
      "protein_binding": "Testosterone is 40% bound to sex hormone binding globulin, 2% unbound, and the remainder is bound to albumin and other proteins.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            },
            {
                  "AOP_id": 167,
                  "AOP_name": "Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse. "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",
            "Androgen receptor",
            "Cytochrome P450 19A1",
            "Cytochrome P450 3A4",
            "Estrogen receptor alpha",
            "Estrogen receptor beta",
            "Lanosterol 14-alpha demethylase",
            "Mineralocorticoid receptor",
            "Sex hormone-binding globulin",
            "Sigma non-opioid intracellular receptor 1"
      ]
}